Trial intelligence / Profile preview

sPIF in Autoimmune Hepatitis

NCT03593460Phase 2Withdrawn

Start
Jan 2019
Primary completion
Nov 2019
Modality
Antisense DNA, Small Interfering RNA (siRNA), Peptides
01

Overview

A Phase 2 trial of synthetic preimplantation factor in autoimmune hepatitis (AIH). Planned start Jan 2019; status: withdrawn.

02

Drugs

synthetic preimplantation factor
03

Conditions

autoimmune hepatitis (AIH)

Beyond the preview

Go deeper on NCT03593460.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03593460.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call